Rosuzet Composite Pack is a medicine containing the active ingredient(s) rosuvastatin, ezetimibe. On this page you will find out more about Rosuzet Composite Pack, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: rosuvastatin
Active ingredient in this medicine: ezetimibe
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Rosuzet Composite Pack (30 x 5 mg tablets, 30 x 10 mg tablets), 1 pack
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
Primary Hypercholesterolaemia: ROSUZET Composite Pack is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients: - not appropriately controlled with rosuvastatin or ezetimibe alone; or - already treated with rosuvastatin and ezetimibe. Homozygous Familial Hypercholesterolaemia (HoFH): ROSUZET Composite Pack is indicated for patients with HoFH. Patients may also receive adjunctive treatments (e.g., LDL apheresis).
Table of characteristics
20 tablets: Prescription Only Medicine, or Prescription Animal Remedy
60 tablets: Prescription Only Medicine, or Prescription Animal Remedy
|Visual appearance||A white to off white, capsule-shaped tablet debossed with "414" on one side|
|Route of administration||Oral|
|Visual appearance||White to off-whiten, round, film coated tablets with "RSV 5" debossed on one side.|
|Dosage Form||Tablet, film coated|
|Route of administration||Oral|
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 25 degrees Celsius|
|Storage conditions||Store in Original Container|
|Life time||2 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 March 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.